Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

Lexicon Pharmaceuticals, ordinary share
LXRX, US5288723027

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Lexicon Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Try in 7-days Trial access

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a ...
Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.
  • Issuer
  • Full borrower / issuer name
    Lexicon Pharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LXRX
  • Placement
    02.02.2026
  • Lock up period
    180
  • Number of papers
    32,000,000
  • Volume of raised funds
    41.6 mln USD
  • Raised funds in USD
    -
  • Placement share
    7.49%
  • Final placement price
    1.3 USD
  • Price change since placement date
    40.38%
  • By capitalization
    555.21 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LXRX
  • Placement
    29.07.2022
  • Lock up period
    180
  • Number of papers
    16,843,600
  • Volume of raised funds
    42.11 mln USD
  • Raised funds in USD
    -
  • Placement share
    9.17%
  • Final placement price
    2.5 USD
  • Price change since placement date
    -27%
  • By capitalization
    458.98 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LXRX
  • Placement
    24.11.2014
  • Lock up period
    180
  • Number of papers
    49,751,244
  • Volume of raised funds
    50.25 mln USD
  • Raised funds in USD
    -
  • Placement share
    6.97%
  • Final placement price
    1.01 USD
  • Price change since placement date
    81.59%
  • By capitalization
    717.41 mln USD

Indicators

News

All organization news

Holders

Related Stock indices

  • NASDAQ Composite
    27,068.72
    Value
    25/09/2026
    Date

Industry Leaders

Registration is required to get access.